Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Modelling the Cost Effectiveness of Disease-Modifying Treatments for Multiple Sclerosis : Issues to Consider.
The Central Role of Neuroscientists under National Socialism.
Tumefactive demyelination following herbal supplement use: Cause or coincidence?
A MS-lesion pattern discrimination plot based on geostatistics.
Fampridine improves severe dysarthria in secondary-progressive multiple sclerosis.
Neurological perspectives on voltage-gated sodium channels.
Venous Hemodynamic Insufficiency Severity Score variation after endovascular treatment of chronic cerebrospinal venous insufficiency.
Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
Acute disseminated encephalomyelitis mimicking acute meningoencephalitis.
A method for estimating intracellular sodium concentration and extracellular volume fraction in brain in vivo using sodium magnetic resonance imaging.
Similarities between Inherited Demyelinating Neuropathies and Wallerian Degeneration: An Old Repair Program May Cause Myelin and Axon Perturbation under Nonlesion Conditions.
New Strategies in the Management of Guillain-Barré Syndrome.
Consequences of perinatal bisphenol A exposure in a mouse model of multiple sclerosis.
Jean-Martin Charcot, father of modern neurology: an homage 120 years after his death.
Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I).
The gateway theory: How regional neural activation creates a gateway for immune cells via an inflammation amplifier.
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores.
Construction and Characterization of Recombinant HEK Cell Over Expressing α4 Integrin.
Association between a Functional HLA-G 14-bp Insertion/deletion Polymorphism and Susceptibility to Autoimmune Diseases: A Meta-analysis.
Understanding hope in patients with Multiple Sclerosis.
Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis.
Coping Among Individuals With Multiple Sclerosis: Evaluating a Goodness-of-Fit Model.
Multiple Sclerosis.
The myelin proteolipid plasmolipin, forms oligomers and induces liquid ordered membranes in the Golgi apparatus.
Label-free method for anti-glucopeptide antibody detection in Multiple Sclerosis.
Pages
« first
‹ previous
…
467
468
469
470
471
472
473
474
475
…
next ›
last »